p27 Modulates Cell Cycle Progression and Chemosensitivity in Human Malignant Glioma
- 11 August 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 261 (3) , 890-896
- https://doi.org/10.1006/bbrc.1999.1126
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patientsNature Medicine, 1997
- Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agentsNature Medicine, 1996
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Cell, 1996
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996
- Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1.Journal of Clinical Investigation, 1996
- Translational Control of p27 Kip1 Accumulation During the Cell CycleScience, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signalsCell, 1994